DBV Technologies is headquartered in Montrouge, France and is a clinical-stage biopharmaceutical company responsible for developing Viaskin®, an investigational proprietary technology platform with potential applications in immunotherapy. The development of Viaskin® is based on epicutaneous immunotherapy,... Show More
